Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Critical appraisal of the potential use of cannabinoids in cancer management.

Cridge BJ, Rosengren RJ.

Cancer Manag Res. 2013 Aug 30;5:301-13. doi: 10.2147/CMAR.S36105. eCollection 2013. Review.

PMID:
24039449
[PubMed]
Free PMC Article
2.

The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription.

Laprairie RB, Kelly ME, Denovan-Wright EM.

Br J Pharmacol. 2012 Dec;167(8):1583-95. doi: 10.1111/j.1476-5381.2012.02175.x. Review.

PMID:
22924606
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.

Horváth B, Mukhopadhyay P, Kechrid M, Patel V, Tanchian G, Wink DA, Gertsch J, Pacher P.

Free Radic Biol Med. 2012 Apr 15;52(8):1325-33. doi: 10.1016/j.freeradbiomed.2012.01.014. Epub 2012 Jan 31.

PMID:
22326488
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells.

Wasik AM, Almestrand S, Wang X, Hultenby K, Dackland ÅL, Andersson P, Kimby E, Christensson B, Sander B.

Cell Death Dis. 2011 Nov 3;2:e225. doi: 10.1038/cddis.2011.106.

PMID:
22048168
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.

Wang X, Björklund S, Wasik AM, Grandien A, Andersson P, Kimby E, Dahlman-Wright K, Zhao C, Christensson B, Sander B.

PLoS One. 2010 Nov 22;5(11):e14085. doi: 10.1371/journal.pone.0014085.

PMID:
21124928
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.

Gustafsson K, Sander B, Bielawski J, Hannun YA, Flygare J.

Mol Cancer Res. 2009 Jul;7(7):1086-98. doi: 10.1158/1541-7786.MCR-08-0361.

PMID:
19609004
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Emerging strategies for exploiting cannabinoid receptor agonists as medicines.

Pertwee RG.

Br J Pharmacol. 2009 Feb;156(3):397-411. doi: 10.1111/j.1476-5381.2008.00048.x. Review.

PMID:
19226257
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk